A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis

Journal of Infectious Diseases

Volumn 176, Issue 1, 1997, Pages 227-232

  Wilcox, C Mel ^a   Darouiche, Rabih O ^b   Laine, Loren ^b   Moskovitz, Bruce L ^b   Mallegol, Irma ^b   Wu, Jane ^b  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; PLACEBO; POTASSIUM HYDROXIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOSCOPY; ESOPHAGUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; VERTIGO; VOMITING;

EID: 0030941385     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514028     Document Type: Article

References (12)

1. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
2. Greenspan D. Treatment of oropharyngeal candidiasis in HIV-positive patients. J Am Acad Dermatol 1994;31:S51-5.
3. Pons V, Greenspan D, Debruin M, Multicenter Group. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. J Acquir Immune Defic Syndr 1993;6:1311-6.
4. Anassi EO, Egbunike IG, Akpaffiong MJ, Ike EN, Cate TR. Developing and implementing guidelines to promote appropriate use of fluconazole therapy in an AIDS clinic. Hosp Pharm 1994;29:576-8, 581-2, 585-6.
5. Koletar SL, Russell JA, Fass RJ, Plouffe JF. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1990;34:2267-8.
6. Owens NJ, Nightingale CH, Schweizer RT, Schauer PK, Dekker PT, Quintiliani R. Prophylaxis of oral candidiasis with clotrimazole troches. Arch Intern Med 1984;144:290-3.
7. Hay R. Overview of studies of fluconazole in oropharyngeal candidiasis. Rev Infect Dis 1990;12(suppl 3):S334-7.
8. Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome - related complex. Arch Intern Med 1991;151: 2458-64.
9. De Wit S, Goossens H, Weerts D, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989; 1:746-8.
10. Smith DE, Midgley J, Allan M, Connolly GM, Gazzard BG. Itraconazole versus ketoconazole in the treatment of oral and esophageal candidosis in patients infected with HIV. AIDS 1991;5:1367-71.
11. Gritti FM, Raise E, Bonazzi L, et al. Fluconazole treatment for candidiasis and cryptococcosis in patients with AIDS and AIDS-related complex. Curr Ther Res 1990;47:1049-62.
12. Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of candida esophagitis in AIDS: a randomized trial. Ann Intern Med 1992;117:655-60.